{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:23:02Z","timestamp":1786998182857,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.yebeh.2024.110032","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T17:09:54Z","timestamp":1729444194000},"page":"110032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Psychiatric comorbidities before and after cannabidiol treatment in adult patients with drug resistant focal epilepsy"],"prefix":"10.1016","volume":"160","author":[{"given":"Juli\u00e1n","family":"Lamonarca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8735-036X","authenticated-orcid":false,"given":"In\u00e9s","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Bayarres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0513-3534","authenticated-orcid":false,"given":"Silvia","family":"Kochen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1365-2924","authenticated-orcid":false,"given":"Silvia","family":"Oddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yebeh.2024.110032_b0005","first-page":"293","article-title":"The origin and use of cannabis in East Asian linguistic-cultural implications","volume":"28","author":"Li","year":"1974","journal-title":"Botanica Economical"},{"issue":"9","key":"10.1016\/j.yebeh.2024.110032_b0010","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/acn3.621","article-title":"A prospective open-label trial of a CBD\/THC cannabis oil in Dravet syndrome","volume":"5","author":"McCoy","year":"2018","journal-title":"Ana clinical translation Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2024.110032_b0015","first-page":"211","article-title":"Cannabidiol in the treatment of epilepsy","volume":"41","author":"Von Wrede","year":"2021","journal-title":"Clinical Drug Research"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110032_b0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s13311-015-0375-5","article-title":"\u201cCannabinoids and epilepsy\u201d","volume":"12","author":"Rosenberg","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.yebeh.2024.110032_b0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00406-019-00984-4","article-title":"How effective and safe is medical cannabis as a treatment for mental disorders? A systematic review","volume":"269","author":"Hoch","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2024.110032_b0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"\u201cDefinition of drug-resistant epilepsy: consensus proposal of the ILAE Commission ad hoc Task Force on Therapeutic Strategies\u201d","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110032_b0035","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110032_b0040","doi-asserted-by":"crossref","DOI":"10.18294\/sc.2022.3991","article-title":"Cannabis medicinal","volume":"Vol: 18","author":"Kochen","year":"2022","journal-title":"Salud Colectiva"},{"issue":"2","key":"10.1016\/j.yebeh.2024.110032_b0045","first-page":"202","article-title":"\u201cArtisanal cannabis in young and adults patients with treatment resistant epilepsy: prospective, observational, open-label study\u201d","volume":"4","author":"Kochen","year":"2018","journal-title":"Journal of Neurology and Neurological Disorders."},{"key":"10.1016\/j.yebeh.2024.110032_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109210","article-title":"Cannabidiol as adjuvant treatment in adults with drug- resistant focal epilepsy","volume":"144","author":"Kochen","year":"2023","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2024.110032_b0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3988\/jcn.2021.17.2.176","article-title":"Systematic literature review of psychiatric comorbidities in adults with epilepsy","volume":"17","author":"Lu","year":"2021","journal-title":"J Clin Neurol"},{"issue":"part B","key":"10.1016\/j.yebeh.2024.110032_b0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.yebeh.2018.07.023","article-title":"\u201cCommon psychiatric comorbidities in epilepsy: how big a problem?\u201d","volume":"98","author":"Salpekar","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110032_b0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yebeh.2018.06.046","article-title":"Interictal psychiatric comorbidities of drug-resistant focal epilepsy: prevalence and influence of epilepsy location","volume":"94","author":"Jansen","year":"2019","journal-title":"Epilepsy and Behavior: E&B"},{"key":"10.1016\/j.yebeh.2024.110032_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108331","article-title":"Behavioral Impulsivity comorbid after one year of epilepsy surgery","volume":"124","author":"Gonzalez Stivala","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110032_b0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2014.06.002","article-title":"Psychiatric outcome of epilepsy surgery in patients with psychosis and pharmacoresistant temporal lobe epilepsy: a prospective case series","volume":"37","author":"D'Alessio","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110032_b0080","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.yebeh.2009.09.017","article-title":"Preoperative depressive symptoms predict postoperative seizure outcome in temporal and frontal lobe epilepsy","volume":"16","author":"Metternich","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110032_b0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yebeh.2017.01.007","article-title":"To what extent does depression influence the quality of life of people with drug-resistant epilepsy in Argentina?","volume":"69","author":"Sc\u00e9vola","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110032_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2019.01.003","article-title":"Physicians' guide to cannabidiol and hemp oils","author":"VanDolah","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.yebeh.2024.110032_b0095","doi-asserted-by":"crossref","unstructured":"Bonaccorso S., Ricciardi A.,Zangani C., Chiappini S. and Schifano F. (2019). \u201cCannabidiol (CBD) use in psychiatric disorders: a systematic. NeuroToxicology\u201d 10.1016\/jneuro.2019.08.002.","DOI":"10.1016\/j.neuro.2019.08.002"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110032_b0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/acn3.51537","article-title":"Observational study of medical marijuana as a treatment for treatment-resistant epilepsies","volume":"9","author":"Devinsky","year":"2022","journal-title":"Ann Clin Transl Neurol."},{"issue":"2","key":"10.1016\/j.yebeh.2024.110032_b0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.11613\/BM.2014.022","article-title":"Observational and interventional study design types; an overview","volume":"24","author":"Thiese","year":"2014","journal-title":"Biochemia Medica."},{"key":"10.1016\/j.yebeh.2024.110032_b0110","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2014). DSM-5. Diagnostic and Statistical Manual of Mental Disorders. Editorial Panamericana.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.yebeh.2024.110032_b0115","unstructured":"Pereyra CR. Semiolog\u00eda y psicopatolog\u00eda de los procesos de la esfera intelectual. Buenos Aires: Editorial Salerno; 2000."},{"key":"10.1016\/j.yebeh.2024.110032_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-019-01171-4","article-title":"Pharmacological and therapeutic properties of cannabidiol for epilepsy","author":"Franco","year":"2019","journal-title":"Drug"},{"key":"10.1016\/j.yebeh.2024.110032_b0125","unstructured":"Beck, AT and Steer, RA (2011). BAI: Beck Anxiety Inventory."},{"key":"10.1016\/j.yebeh.2024.110032_b0130","doi-asserted-by":"crossref","unstructured":"Beck, AT, Steer, RA and Brown, GK (1996). Beck Depression Inventory (BDI-II) (Vol. 10, No. 3). London, UK: Pearson.","DOI":"10.1037\/t00742-000"},{"key":"10.1016\/j.yebeh.2024.110032_b0135","doi-asserted-by":"crossref","unstructured":"Beck AT, Rard CH, Mendelson C, Mock J, and Erbaugh J. An inventory to measure depression. Archives of general psychiatry. 1961; 4:1961-1971 54. Beck AT, Steer RA and Garbin MG. \u201cPsychometric properties of the Beck Depression Inventory: twenty-five years of evaluation\u201d. Review of Clinical Psychology 1988; 8:77-100.","DOI":"10.1016\/0272-7358(88)90050-5"},{"issue":"6","key":"10.1016\/j.yebeh.2024.110032_b0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1528-1157.1996.tb00612.x","article-title":"A brief questionnaire to screen for quality of life in epilepsy. The QOLIE-10","volume":"37","author":"Cramer","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110032_b0145","first-page":"3","article-title":"Morales M.D.; group of investigators of the validation study of the QOLIE-10 questionnaire. \u201cValidation of the Spanish version of the QOLIE-10 questionnaire of quality of life in epilepsy\u201d","volume":"23","author":"Viteri","year":"2008","journal-title":"Neurologia"},{"issue":"5","key":"10.1016\/j.yebeh.2024.110032_b0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/occmed\/kqu024","article-title":"The hospital anxiety and depression scale","volume":"64","author":"Stern","year":"2014","journal-title":"Occup Med"},{"issue":"6","key":"10.1016\/j.yebeh.2024.110032_b0155","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"15","key":"10.1016\/j.yebeh.2024.110032_b0160","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1017\/S0033291715001270","article-title":"Clinically important minimal difference on the Beck Depression Inventory II according to patient perspective","volume":"45","author":"Button","year":"2015","journal-title":"Psychol Med."},{"key":"10.1016\/j.yebeh.2024.110032_b0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","article-title":"Clinical significance: A statistical approach to defining meaningful change in psychotherapeutic research","volume":"59","author":"Jacobson","year":"1991","journal-title":"Journal of Clinical and Consulting Psychology"},{"issue":"3","key":"10.1016\/j.yebeh.2024.110032_b0170","doi-asserted-by":"crossref","first-page":"p270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.yebeh.2024.110032_b0175","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ncl.2009.08.002","article-title":"Depression and epilepsy: a review of a multiple facets of a their close relation","volume":"27","author":"Kanner","year":"2009","journal-title":"Neurol Clin"},{"key":"10.1016\/j.yebeh.2024.110032_b0180","article-title":"Psychiatric comorbidities in patients with epilepsy","author":"Mula","year":"2020","journal-title":"Neurology: Clinical Practice"},{"issue":"2","key":"10.1016\/j.yebeh.2024.110032_b0185","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yebeh.2012.01.007","article-title":"\u201cDepression and epilepsy: epidemiological and neurobiological perspectives that may explain their high occurrence of comorbidities\u201d","volume":"24","author":"Kanner","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110032_b0190","doi-asserted-by":"crossref","unstructured":"Murillo- Rodriguez E., Pandi-Perumal SR., and Monti, JM (Eds.) (2021). \u201cCannabinoids and neuropsychiatric disorders, Advances in Experimental Medicine and Biology\u201d. Doi: 10.1007\/978-3-030-57369-0.","DOI":"10.1007\/978-3-030-57369-0"},{"key":"10.1016\/j.yebeh.2024.110032_b0195","article-title":"Cannabidiol use in anxiety and anxiety-related disorders","author":"Skelley","year":"2019","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.yebeh.2024.110032_b0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbr.2016.01.033","article-title":"Antidepressant effect of cannabidiol injection in the ventral medial prefrontal cortex: possible involvement of 5-HT1A and CB1 receptors","volume":"303","author":"Sartim","year":"2016","journal-title":"Behavioral Brain Research"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024004141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024004141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T07:41:24Z","timestamp":1730878884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024004141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":40,"alternative-id":["S1525505024004141"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110032","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric comorbidities before and after cannabidiol treatment in adult patients with drug resistant focal epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110032"}}